Table 2.
HIV REPORTED RISKS | Total | Primary HIV resistance† n=64 | p-value* |
---|---|---|---|
| |||
n | n (%) | ||
Occupational Exposure | |||
exposure to needle or body fluids, ever | 67 | 6 (9.0) | 0.4 |
Non Occupational Exposure | |||
Body piercing,ever | 111 | 14 (12.6) | 0.9 |
Tattoos,ever | 125 | 19 (15.2) | 0.3 |
Acunpuncture,ever | 32 | 4 (12.5) | 0.9 |
Surgery procedure, ever | 328 | 44 (13.4) | 0.4 |
Endoscopic/colonoscopic procedure, ever | 103 | 13 (12.6) | 0.9 |
PWID‡ ever (injected any drugs or non-prescription substances) | 79 | 11 (13.9) | 0.7 |
Blood transfusion, ever | 19 | 3 (15.8) | 0.7 |
Inmate, ever | 11 | 0 (0.0) | 0.4 |
Sexual exposure | |||
SEX with | |||
Inmate, ever | 31 | 4 (12.9) | 0.8 |
blood transfusion recipient, ever | 24 | 2 (8.3) | 0.8 |
HIV positive partner, ever | 42 | 4 (9.5) | 0.6 |
HIV positive partner taking ART, ever | 42 | 4 (9.5) | 0.6 |
PWID ever | 29 | 4 (13.8) | 0.7 |
person with potential job exposure, ever | 51 | 7 (13.7) | 0.8 |
Sexual partner of MSM§ - males* | 162 | 27 (16.7) | 0.1 |
Sexual partner of MSM§ - females* | 3 | 0 (0.0) | 0.9 |
MSM§, ever | 195 | 26 (13.3) | 0.8 |
Lifetime number of sex partners | |||
0 | 5 | 1 (20.0) | 0.6 |
1 | 21 | 1 (4.8) | |
2 – 3 | 53 | 6 (11.3) | |
4 – 6 | 104 | 14 (13.5) | |
7 – 10 | 71 | 11 (15.5) | |
11 – 20 | 80 | 15 (18.8) | |
21+ | 69 | 6 (8.7) | |
Number of sex partners, in the last 12 months | |||
0 | 20 | 4 (20.0) | 0.2 |
1 | 182 | 17 (9.3) | |
2 – 3 | 168 | 26 (15.5) | |
4 – 6 | 61 | 9 (14.8) | |
7 – 10 | 23 | 2 (8.7) | |
11+ | 16 | 0 (0.0) |
Last 12 months
From the sequenced samples n=275 (71.2%)
Person who injected drugs or non-prescription substance (PWID)
Men who have sex with men (MSM)
Totals must be less due to missing values